![]() |
![]() |
![]() |
![]() |
![]() |
![]() ![]() ![]() ![]() ![]() ![]() |
Prospective randomized trial comparing relapse rates in dogs with steroid-responsive meningitis-arteritis treated with a 6-week or 6-month prednisolone protocol.J Vet Intern Med. 2024 Jul-Aug;38(4):2221 - 2227.1 Lumbry Park Veterinary Specialists, CVS Group plc, Alton, United Kingdom.; 2 Lumbry Park Veterinary Specialists, CVS Group plc, Alton, United Kingdom.; 3 Lumbry Park Veterinary Specialists, CVS Group plc, Alton, United Kingdom.; 4 Cave Veterinary Specialists, Linnaeus group, Wellington, United Kingdom.; 5 Lumbry Park Veterinary Specialists, CVS Group plc, Alton, United Kingdom.; 6 College of Veterinary Medicine, North Carolina State University, Raleigh, USA.; 7 Blaise Referrals, IVC Evidensia Referrals, Birmingham, United Kingdom.; 8 CVS Group plc, Diss, United Kingdom.; 9 Paragon Veterinary Referrals, Linnaeus group, Wakefield, United Kingdom.; 10 Bristol Vet Specialists, CVS Group plc, Bristol, United Kingdom.; 11 Langford Small Animal Hospital, Bristol Veterinary School, University of Bristol, Bristol, United Kingdom.
© 2024 The Author(s). Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.
AbstractBACKGROUND:Traditionally, 6-month courses of prednisolone are used to treat steroid-responsive meningitis-arteritis (SRMA), but this medication is associated with adverse effects that can lead to poor quality of life.
HYPOTHESIS/OBJECTIVES:Resolution of clinical signs and rate of relapse of SRMA would not be significantly different between a 6-month prednisolone protocol and a 6-week protocol.
ANIMALS:Forty-four hospital cases from multiple referral centers in the United Kingdom (2015-2019). Twenty of 44 were treated with the 6-month protocol and 24/44 with the 6-week protocol.
METHODS:Prospective, randomized trial with 12-month follow-up. The same prednisolone protocol reinitiated in the event of relapse. Analysis of relapses with binary logistic and Poisson regression modeling.
RESULTS:All cases responded to their treatment protocol. Relapses occurred in 6/20 (30%) of the 6-month protocol and 9/24 (38%) of the 6-week protocol. There was no statistical difference in the incidence risk of at least 1 relapse between the 2 groups (odds ratio = 1.40; 95% confidence interval [CI], 0.40-4.96, P = 0.60). Among the 15 dogs that relapsed, 10/15 (67%) relapsed once, 3/15 (20%) relapsed twice, and 2/15 (13%) relapsed 3 times. No statistical difference was detected in the incidence rate ratio (IRR) of total relapse events between the 2 groups (IRR = 1.46; 95% CI, 0.61-3.48; P = 0.40).
CONCLUSIONS AND CLINICAL IMPORTANCE:"Short" 6-week prednisolone protocols could be used to treat SRMA, thereby presumably reducing the duration and severity of prednisolone's adverse effects.
Keywords![]()
|
![]() |
Article Tools:
Archives Highlights:
|
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
800.700.4636 | help@vspn.org | 530.756.4881 | Fax: 530.756.6035
777 West Covell Blvd, Davis, CA 95616 Copyright 1991-2025, Veterinary Information Network, Inc. |
Contact Us |